Patient & Visitor Alert: Because flu cases are on the rise, starting February 24, children 12 and younger will be restricted from visiting hospitals and certain inpatient facilities throughout Carolinas HealthCare System. Learn more.
A Phase III, Multicenter, Randomised, Double-Blind, Parallel Group, Placebo Controlled Study to Assess the Efficacy and Safety of one or more Intradetrusor Treatments of 600 or 800 Units of Dysport for the Treatment of Urinary Incontinence in Subjects With Neurogenic Detrusor Overactivity Due to Spinal Cord Injury or Multiple Sclerosis
Who may be Eligible
Male or female, aged 18 to 80 years inclusive with UI for at least 3 months prior to screening as a result of NDQ due to SCI or MS.